Table 1 Dysregulated expression microRNAs (P < 0.05) with at least twofold of log2 fold change obtained from comparisons in specimens from case and control participants respectively
From: MicroRNA-142-5p contributes to Hashimoto’s thyroiditis by targeting CLDN1
HT group (HT vs. normal) | HTa group (HTa vs. normal) | ||||
|---|---|---|---|---|---|
MicroRNA name | Log2 FC | P value | MicroRNA name | Log2 FC | P value |
hsa-miR-142-5p | 7.959 | 0.005 | hsa-miR-338-3p | 4.386 | 0.019 |
hsa-miR-221a | 5.534 | 0.002 | hsa-miR-29b-1a | 4.083 | 0.012 |
hsa-miR-142-3p | 4.236 | 0.011 | hsa-miR-363 | 3.964 | 0.026 |
hsa-miR-338-3p | 4.196 | 0.023 | hsa-miR-454 | 3.946 | 0.021 |
hsa-miR-454 | 4.105 | 0.024 | hsa-miR-194 | 3.71 | 0.031 |
hsa-miR-146a | 3.731 | 0.016 | hsa-miR-142-3p | 2.698 | 0.036 |
hsa-miR-650 | 3.677 | 0.028 | hsa-miR-342-5p | 2.483 | 0.034 |
hsa-miR-29b-1a | 3.39 | 0.026 | hsa-miR-146a | 2.406 | 0.029 |
hsa-miR-625 | 3.325 | 0.041 | hsa-miR-150 | 2.211 | 0.021 |
hsa-miR-342-5p | 3.278 | 0.020 | hsa-miR-223 | 2.151 | 0.016 |
hsa-miR-150 | 3.111 | 0.006 | hsa-miR-654-5p | −3.362 | 0.037 |
hsa-miR-155 | 3.067 | 0.011 | hsa-miR-601 | −5.076 | 0.011 |
hsa-miR-21 | 2.931 | 0.007 | hsa-miR-198 | −5.536 | 0.038 |
hsa-miR-223 | 2.446 | 0.007 | hsa-miR-1226a | −6.017 | 0.001 |
hsa-miR-513a-5p | −2.057 | 0.009 | |||
hsa-miR-1285 | −4.761 | 0.037 | |||
hsa-miR-654-5p | −4.861 | 0.005 | |||
hsa-miR-200ba | −5.122 | 0.004 | |||
hsa-miR-198 | −5.514 | 0.038 | |||
hsa-miR-601 | −5.957 | 0.001 | |||
hsa-miR-1226a | −5.996 | 0.001 | |||